Sign up
Log in
BUZZ-U.S. STOCKS ON THE MOVE-Iovance Biotherapeutics, The9, Guardant Health
Share
Listen to the news
BUZZ-U.S. STOCKS ON THE MOVE-Iovance Biotherapeutics, The9, Guardant Health

Eikon search string for individual stock moves: STXBZ

The Day Ahead : https://refini.tv/3LI4BU7

The Morning News Call : https://refini.tv/3dKUyB8

U.S. stock index futures rose on Friday, rebounding after Wall Street closed lower in the previous session on signs of persistent inflation that rekindled monetary policy caution ahead of a long weekend. .N


At 7:38 ET, Dow e-minis 1YMc1 were up 0.08% at 39,185. S&P 500 e-minis ESc1 were up 0.24% at 5,298, while Nasdaq 100 e-minis NQc1 were up 0.24% at 18,740.75.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Enzo Biochem Inc , up 14.3%
** Companhia Energetica de Minas Gerais CEMIG , up 14.2%
** Lanvin Group Holdings Ltd , up 10.8%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Barnes & Noble Education Inc , down 21.1%
** Nomura Holdings Inc , down 7.7%
** Emeren Group Ltd , down 7.1%

The top three Nasdaq percentage gainers premarket .PRPG.O:
** Akanda Corp , up 135.1%
** Netcapital Inc , up 66.5%
** Cue Health Inc , up 50.1%

The top three Nasdaq percentage losers premarket .PRPL.O:
** Sensei Biotherapeutics Inc , down 38.8%
** Verastem Inc , down 36.9%
** Genelux Corporation , down 27.4%


** Workday Inc WDAY.O: down 11.5% premarket
BUZZ - Slumps after trimming Q2 subscription revenue


** Apple Inc AAPL.O: up 0.6% premarket
BUZZ - Wedbush raises Apple PT to reflect higher AI monetization opportunities, China turnaround


** Iovance Biotherapeutics Inc IOVA.O: up 8.0% premarket
BUZZ - Climbs on positive mid-stage data for skin cancer treatment


** The9 Ltd NCTY.O: up 7.6% premarket
BUZZ - Jumps on raising $3.5 mln in private placement deal


** Guardant Health Inc GH.O: up 8.8% premarket
BUZZ - Rises as US FDA advisers back approval of cancer test


(Compiled by Rajarshi Roy and Roshia Sabu in Bengaluru)

((Rajarshi.Roy@thomsonreuters.com))

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.